Loading…
Loading…
Enables natural orifice extraction of tissue without surgical incision SINGAPORE, July 20, 2026 /PRNewswire/ -- NICE Surgical Solutions Pte Ltd ("NICE Surgical"), a clinical-stage medical device company pioneering full intracorporeal anastomosis surgical instruments, has been granted U.S. Patent No. 12,661,097 B2, for its extracting device used in conjunction with its novel purse-string stapler, generally eliminating the need for surgical incisions in colorectal surgery.
Enables intracorporeal purse-sting suturing, stapling, and resection in a single firing SINGAPORE, July 1, 2026 /PRNewswire/ -- NICE Surgical Solutions Pte Ltd ("NICE Surgical"), a clinical-stage medical device company pioneering full intracorporeal anastomosis surgical instruments has been officially granted the U.S. Patent No. 12,653,527 B2, for its purse-string stapler.
Pfizer Inc (NYSE:PFE) stock is down 1.1% to trade at $26.03 at last check.
POC included in vivo insect validation of de novo designed proteins NES TZIONA, Israel, March 10, 2026 /PRNewswire/ -- IBI Ag Ltd. ('IBI Ag'), a leader in sustainable agricultural solutions, has today announced the successful completion of its proof of concept (POC) for the AI-driven platform for de novo design of novel bioinsecticide proteins.
Last week looked like a strong start for a Santa Claus rally
Oil and gas prices rebound 6% from five-year lows as geopolitical tensions add a risk premium, while technical resistance and surplus forecasts cap longer-term upside.
“There is potential resistance overhead from the lower boundary of the bull channel that was in place from June through mid-November.
This is the second and final tranche of IBI Ag's Series A Round for its novel bioinsecticide platform NESS ZIONA, Israel , Nov. 11, 2025 /PRNewswire/ -- IBI Ag, a pioneering crop protection company developing a wide array of bio-insecticides with a lower ecological footprint, today announced the successful completion of its Series A funding round for a total of $10 million. The investment was led by Corteva ("Corteva") through its Corteva Catalyst platform, with the participation of The Trendlines Group (SGX:42T) (OTCQX: TRNLY), Iron Nation, Consensus Business Group ("CBG"), and a grant from the Israel Innovation Authority, joined by Bandera Capital and First Imagine Ventures, enabling the closing of the round.
No recent filings indexed.